TP53 mutation load was associated with smoking dose and duration in a case–control study of lung cancer (Hagiwara et al. 2006), supporting the fact that mutations in CFDNA may serve as reporters of diverse forms of carcinogenic exposures. The gene discussed is TP53; the disease is lung cancer.